Mithryon
Other
Berlin, Germany12 profile visits
About
building an AI-enabled platform to identify novel tumor degraders and prioritise opportunities for targeted protein degradation and molecular glue therapeutics.
Disease Area
Cancer
Biomedical Research, Medicine, Human Health
Drug Target DiscoveryDiagnostics
Technology
Data science, AI / Machine learningBioengineering(Single-cell) multi-omicsPersonalized disease models
Representatives
(Pre-)Founder
Mithryon